Abstract
Melanomas are the most aggressive types of skin cancer, with low responsiveness to therapy, and are therefore responsible for over 80% of deaths associated with skin neoplasms. The main challenges in treatment are the high cost and low therapeutic efficacy. Thus, we propose that riboflavin photoproducts (RFP) can democratize melanoma treatment. Our research group has demonstrated that med…